文献速递自身炎症与 IgG4 相关病

IgG4相关疾病患者报告症状与困扰的评估:IgG4-RD症状严重程度指数的开发、临床验证与内容验证

Assessment of patient-reported symptoms and distress in IgG4-related disease (IgG4-RD): Development, clinical validation, and content validation of the IgG4-RD Symptom Severity Index.
PubMed 文献 · Semin Arthritis Rheum · 2023-08-18

本研究开发并验证了用于评估IgG4相关疾病(IgG4-RD)症状负担的症状严重程度指数(SSI)。SSI评估24种症状的频率与困扰程度,在136例患者中显示90%存在至少1种症状、88%存在困扰,且SSI与生活质量量表呈负相关,活动期疾病SSI评分高于非活动期。

要点

  • SSI评估24种症状的频率与困扰程度,频率按「从不」0分至「每天」3分、困扰按「无」0分至「非常」4分计分,各症状困扰分求和得总分。
  • 136例完成至少1次SSI的患者中,90%经历至少1种症状,88%存在困扰,中位SSI评分为6.5(IQR 3.0, 18.0)。
  • SSI与SF-36(r=-0.51, p<0.001)、感觉温度计(r=-0.28, p<0.001)及EQ-5D(r=-0.28, p<0.001)呈负相关。

核心结论

  • 症状与困扰在IgG4-RD中常见,并与较差的健康相关生活质量相关。
  • SSI具有表面效度、内容效度和结构效度,且与生活质量测量结果相对应。

研究设计与样本

  • 先导SSI在n=5中测试并发现若干不足,随后进行20次半结构化定性访谈以扩展条目集并识别缺失症状。
  • 修改后的当前SSI与生活质量(QOL)测量一起在n=136中实施,评估症状负担及SSI的结构效度。

主要发现

  • SSI评估24种症状的频率和困扰程度,每种症状的困扰分由症状频率(「从不」0分至「每天」3分)乘以相关困扰(「无」0分至「非常」4分)计算,各困扰分求和得总SSI评分。
  • 在n=136且至少完成1次SSI的患者中,90%经历至少1种症状,88%存在困扰,中位SSI评分为6.5(IQR 3.0, 18.0),49%观察到对更严重疾病的恐惧。
  • SSI与SF-36呈负相关(r=-0.51, p<0.001),与感觉温度计呈负相关(r=-0.28, p<0.001),与EQ-5D呈负相关(r=-0.28, p<0.001)。
  • 在完成超过1次SSI的n=52患者中,活动期疾病的中位SSI评分高于非活动期(15 [6, 26] vs 3 [2, 14], p=0.008)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: IgG4-related disease (IgG4-RD), a multi-organ autoimmune disease, causes diverse manifestations that can lead to symptoms and distress. We developed and validated the Symptom Severity Index (SSI) to assess symptom burden. METHODS: A pilot SSI was tested in n = 5; several gaps were identified. Twenty semi-structured qualitative interviews were performed to expand the item set and identify missing symptoms. Subsequent changes resulted in the current SSI; it was administered with quality of life (QOL) measures to n = 136. We assessed symptom burden and the construct validity of the SSI. A distress score for each symptom is calculated by multiplying symptom frequency ("Never" [0 points] to "Every Day" [3 points]) by associated distress ("None" [0 points] to "Very Much" [4 points]). Each distress score is summed to calculate a total SSI score. RESULTS: The SSI assesses the frequency and distress of 24 symptoms. Among n = 136 with ≥ 1 SSI, 90% experienced ≥ 1 symptom and 88% had distress. The median SSI score was 6.5 (IQR 3.0, 18.0). Fear of more severe disease was observed in 49%. The SSI inversely correlated with the SF-36 (r= - 0.51, p<0.001), the feeling thermometer (r= - 0.28, p<0.001), and the EQ-5D (r= - 0.28, p<0.001). The median SSI score was higher during active vs non-active disease among n = 52 who completed >1 SSI (15 [6, 26] vs. 3 [2, 14], p = 0.008). CONCLUSIONS: Symptoms and distress are common in IgG4-RD and associated with worse health-related QOL. The SSI has face, content, and construct validity; it corresponds with QOL measures.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Wallace ZS, McMahon GA, Hang B, et al. Assessment of patient-reported symptoms and distress in IgG4-related disease (IgG4-RD): Development, clinical validation, and content validation of the IgG4-RD Symptom Severity Index. Semin Arthritis Rheum. 2023. PMID: 37619485. doi:10.1016/j.semarthrit.2023.152253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。